Surgery Websites
Pediatric Liver Center »  Meet Our Team »  Research »  Philip Rosenthal, M.D.
Philip Rosenthal, M.D.

Philip Rosenthal, M.D.

  • Professor of Pediatrics and Surgery Director of Pediatric Hepatology Research Director, Pediatric Hepatology

Contact Information

Academic Office
Room MU 415, Box 0136
University of California, San Francisco
San Francisco, CA 94143-0136
(415) 476-5892
(415) 476-1343 Fax
prosenth@peds.ucsf.edu
Open Popup

1967-71 State Univ. of N.Y. at Albany, Albany, NY, B.S. Magna Cum Laude, Biology
1971-75 State Univ. of N.Y. Downstate Med. Ctr. Brooklyn, NY, M.D. Magna Cum Laude

  • 1975-76 Albert Einstein/Bronx Mun. Hosp., NY, Intern Pediatrics
  • 1976-78 Albert Einstein/Bronx Mun. Hosp., NY, Resident Pediatrics
  • 1978-81 University of California, San Francisco, Fellow Pediatric Gastroenterology
  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Subspeciality in Pediatric Gastroenterology
  • American Board of Pediatrics, Certificate of Added Qualification in Transplant Hepatology
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Liver Center
  • Pediatric Liver Transplant Program
  • Pediatric Intestinal Rehabilitation and Transplantation Program
  • Acute Liver Failure
  • Biliary Atresia
  • Bioartificial Liver Support
  • Choledochal Cyst
  • Cirrhosis
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Liver Cancer)
  • Live Donor Liver Transplantation
  • Liver Transplantation
  • Neonatal Hepatitis
  • Bioartificial liver devices
  • Genetics and immunology of biliary atresia
  • Idiopathic neonatal hepatitis
  • Pediatric Acute Liver Failure (PALF)
  • Quality of life after liver transplants

Philip Rosenthal, M.D. is Professor of Pediatrics and Surgery, Medical Director of the Pediatric Liver Transplant Program. and Director of Pediatric Hepatology at UCSF.  Rosenthal completed his medical training at Downstate Medical Center and the Albert Einstein Medical Center in New York. He then completed a fellowship in pediatric gastroenterology at UCSF. He joined the UCSF faculty in 1995 after serving as Professor of Pediatrics at University of California, Los Angeles (UCLA). 

A  pediatric hepatologist at the UCSF Benioff Children's Hospital, Rosenthal is internationally renowned for the care of children with liver disease, including liver cancer, and  those undergoing liver transplantation. In addition, Rosenthal has and currently serves as Principal Investigator on numerous clinical trials to improve the care of patients with pediatric liver disease.

Rosenthal has won numerous honors for his research including work on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary atresia and the quality of life after liver transplants in children. He is a consultant to organizations such as the American Liver Foundation, Parents of Kids with Infectious Diseases, Alagille Syndrome Alliance, Studies of Pediatric Liver Transplantation (SPLIT), Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). He is also on editorial boards and a regular reviewer for leading professional journals.

  Award  
  Confired By    
  Date    
  • Murray Davidson Award
  • American Academy of Pediatrics
  • 2013
  • Chancellor's Award for Public Service
  • UCSF
  • 2002
  • Rosenthal is pursuing research on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary disease, use of bioartificial liver support utilizing porcine hepatocytes for patients with fulminant liver failure, as well as researching the quality of life following liver transplantation in children. 

    Clinical Research

    Rosenthal is principal investigator on numerous clinical trials including the following:

    View all trials 

    Data provided by UCSF Profiles, powered by CTSI
    • Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda
      Sponsor:
      Sponsor ID:
      Funding Period:
      Apr 2020
      -
      Mar 2025
      Co-Principal Investigator
    • Childhood Liver Disease Research Network (ChiLDReN) - UCSF (CC)
      Sponsor:
      Sponsor ID:
      Funding Period:
      Sep 2002
      -
      May 2024
      Principal Investigator
    • Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jun 2018
      -
      May 2023
      Principal Investigator
    MOST RECENT PUBLICATIONS FROM A TOTAL OF 398
    Data provided by UCSF Profiles, powered by CTSI
    1. Boster JM, Goodrich NP, Spino C, Loomes KM, Alonso EM, Kamath BM, Sokol RJ, Karpen S, Miethke A, Shneider BL, Molleston JP, Kohli R, Horslen SP, Rosenthal P, Valentino PL, Teckman JH, Hangartner TN, Sundaram SS, Childhood Liver Disease Research Network (ChiLDReN). Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease. Hepatol Commun. 2023 11 01; 7(11). View in PubMed
    2. Schwarzenberg SJ, King WC, Ling SC, Murray KF, Mogul D, Rosenthal P, Rodriguez-Baez N, Teckman J, Schwarz KB, Hepatitis B Research Network (HBRN). Change in Health-related Quality of Life in Youth with Chronic Hepatitis B Living in North America:A 5-year Cohort Study. J Pediatr Gastroenterol Nutr. 2023 Sep 27. View in PubMed
    3. Conrad MD, Asua V, Garg S, Giesbrecht D, Niaré K, Smith S, Namuganga JF, Katairo T, Legac J, Crudale RM, Tumwebaze PK, Nsobya SL, Cooper RA, Kamya MR, Dorsey G, Bailey JA, Rosenthal PJ. Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. N Engl J Med. 2023 Aug 24; 389(8):722-732. View in PubMed
    4. Roh ME, Zongo I, Haro A, Huang L, Somé AF, Yerbanga RS, Conrad MD, Wallender E, Legac J, Aweeka F, Ouédraogo JB, Rosenthal PJ. Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study. J Infect Dis. 2023 10 03; 228(7):926-935. View in PubMed
    5. Rosenthal PJ. Proteasome inhibitors: The next generation of antimalarial drugs? Cell Chem Biol. 2023 05 18; 30(5):413-415. View in PubMed
    6. View All Publications

     

    Site Directory
      X